A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
about
RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicityChanges to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccinationNKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.Use of attenuated bacteria as delivery vectors for DNA vaccines.DNA damage response and development of targeted cancer treatments.NKG2D ligands in tumor immunity.Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.
P2860
Q28300038-EF6802AF-F5CA-450D-8F78-B77BE6933CD6Q33525552-B5FA96A8-47E9-4CAB-A3DE-701507B707ECQ36484325-17930746-FEC2-46CA-B489-E0D43C327D87Q36728805-37022D37-A1EA-4EF0-967D-1E9CDDAADD10Q36939423-E1869729-D0D8-4A0C-A20D-1C498103FE81Q37287179-6E4D906E-A2B9-4A80-AEFA-77DA081BDF8CQ39637966-C3181673-5C58-4973-B115-FCF0789E4871Q41956511-A6BC51A3-E941-408E-B4DB-3B7EBC2FA759
P2860
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
@ast
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
@en
type
label
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
@ast
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
@en
prefLabel
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
@ast
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
@en
P2093
P2860
P1433
P1476
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
@en
P2093
Charles D Kaplan
Jörg A Krüger
Ralph A Reisfeld
Rong Xiang
Sung-Hyung Lee
Yunping Luo
P2860
P304
P356
10.1182/BLOOD-2005-10-4231
P407
P577
2005-12-20T00:00:00Z